4//SEC Filing
Carter Martha J. 4
Accession 0001209191-22-043110
CIK 0001322505other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:22 PM ET
Size
5.7 KB
Accession
0001209191-22-043110
Insider Transaction Report
Form 4
Carter Martha J.
Chief Regulatory Officer
Transactions
- Sale
Common Stock
2022-07-22$24.68/sh−106$2,616→ 15,668 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.67 to $25.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Represents 1,430 shares of common stock and 14,238 restricted stock units.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001213040
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:22 PM ET
- Size
- 5.7 KB